Also, miRNA-34a restoration improved cisplatin sensitivity in bladder cancer cell lines via transcriptional suppression of SIRT1 and Cdk6. Besides, increasing miRNA-34b expression enhanced susceptibility to gemcitabine, doxorubicin, and methotrexate, as well as triggered apoptosis. This evidence concerns the gene SIRT1 and urinary bladder carcinoma.